ACT for ALS Reauthorized Through 2031 After Presidential Signing
Image
Arlington, Virginia – November 03, 2026 -- The President has signed the bipartisan ACT for ALS Act into law, extending the research and treatment access programs created under the original 2021 legislation through 2031, according to the ALS Association.
Reauthorization keeps 2021 research and access programs running to 2031
The measure continues the programs established when ACT for ALS first passed in 2021. The ALS Association says those programs have accelerated research into promising therapies. The reauthorization is built to help the field establish which treatments work and to deliver them to everyone living with ALS.